Kelley Boucher

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Kelley Boucher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelley Boucher:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief People Officer Common Stock 127,804 $3,210,449 $25.12 28 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Chief People Officer Stock Option (Right to Buy) 45,766 $1,306,808 $19.39 02 Sep 2025 Direct

Insider Reports Filed by Kelley Boucher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2026 1 $0 4 Chief People Officer 30 Jan 2026, 16:13
APLS Apellis Pharmaceuticals, Inc. 02 Sep 2025 2 $0 4 Chief People Officer 03 Sep 2025, 11:55
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 2 +$1,306,808 4 Chief People Officer 11 Jun 2025, 16:27
APLS Apellis Pharmaceuticals, Inc. 28 May 2025 2 +$553,997 4 Chief People Officer 29 May 2025, 11:46
APLS Apellis Pharmaceuticals, Inc. 28 May 2025 0 $0 3 Chief People Officer 29 May 2025, 11:44